EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe

Makoto Onohara iD, Mamoru Narukawa

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70195 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Makoto Onohara und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine (Pharmaceutical Medicine), graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan. Hauptthemen laut MEDLINE: Drug Labeling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The objective of this study was to compare the prescribing information for elderly patients on drug labels in Japan, the United States (U.S.), and Europe to suggest improvements in Japanese package inserts.

Methods

We surveyed drug labeling regulations in the three regions and selected 39 new drugs approved in Japan between 2012 and 2023 for diseases common in the elderly and approved in the U.S. and Europe. We examined the prescribing information for elderly patients such as dose adjustment instructions and comparison of safety profiles by age.

Results

The results revealed that 7.7% of Japanese package inserts provided dosage adjustment instruction for elderly patients, compared with 46.2% and 79.5% of U.S. and European drug labels, respectively. Regarding safety profile comparisons between age groups, 30.8% of Japanese package inserts included this information compared with 94.9% and 23.1% of U.S. and European drug labels, respectively. No Japanese package inserts listed the number of elderly patients included in clinical trials; whereas this information appeared on 89.7% of U.S. labels and 7.7% of European summaries of product characteristics.

Conclusions

Japanese package inserts provide less prescribing information for elderly patients than U.S. and European drug labels. To promote appropriate drug use among elderly patients in Japan, package inserts should be improved by incorporating sufficient information, such as clear dosage adjustment instructions and differences in safety profiles by age groups. These enhancements would align Japanese package inserts with international quality, providing healthcare professionals with more comprehensive drug prescribing information for treating elderly patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug LabelingHumansUnited StatesJapanAgedEuropeAge FactorsAged, 80 and overDrug-Related Side Effects and Adverse Reactions

Stichwörter der Autor:innen

adjustment of dosage and administration for elderly patientsclinical development programdifferences in safety profile by agedrug labelelderly patientsprescribing informationsafety data evaluation

Autor:innen und Institutionen

  • Department of Clinical Medicine (Pharmaceutical Medicine), graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.

ORCID-Profile: Makoto Onohara

Zitieren

APA

Onohara, M., & Narukawa, M. (2025). Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70195

Vancouver

Onohara M, Narukawa M. Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70195

BibTeX
@article{Onohara2025,
  author = {Onohara, Makoto and Narukawa, Mamoru},
  title = {Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70195}
}
Kostenlos starten →